open access

Vol 78, No 6 (2010)
REVIEWS
Published online: 2010-10-29
Submitted: 2013-02-22

Consolidation therapy in advanced non-small cell lung cancer

Renata Duchnowska
Pneumonol Alergol Pol 2010;78(6):439-444.

open access

Vol 78, No 6 (2010)
REVIEWS
Published online: 2010-10-29
Submitted: 2013-02-22

Abstract

Standard management of advanced non-small cell lung cancer includes palliative chemotherapy, but its efficacy is modest. In most cases a few cycles of palliative chemotherapy are administered, as there is no evidence of benefit associated with prolonged treatment. Recently, there is an interest in a new approach including treatment continuation using cytotoxic compounds of proved efficacy in second-line treatment, such as docetaxel and pemetrexed, or targeted agents (erlotinib, gefitinib, cetuximab and bevacizumab). This review presents the current knowledge on this therapeutic strategy including the results of most relevant phase III studies and their metaanalyses.
Pneumonol. Alergol. Pol. 2010; 78, 6: 439-444

Keywords

non-small cell lung cancer; chemotherapy; maintenance therapy; docetaxel; pemetrexed; targeted therapies

About this article
Title

Consolidation therapy in advanced non-small cell lung cancer

Journal

Advances in Respiratory Medicine

Issue

Vol 78, No 6 (2010)

Pages

439-444

Published online

2010-10-29

Bibliographic record

Pneumonol Alergol Pol 2010;78(6):439-444.

Keywords

non-small cell lung cancer
chemotherapy
maintenance therapy
docetaxel
pemetrexed
targeted therapies

Authors

Renata Duchnowska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl